USPL1
Basic information
Region (hg38): 13:30617693-30660770
Previous symbols: [ "C13orf22" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USPL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 86 | 12 | 98 | |||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 87 | 12 | 0 |
Variants in USPL1
This is a list of pathogenic ClinVar variants found in the USPL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-30621148-A-T | not specified | Uncertain significance (Mar 07, 2024) | ||
13-30621216-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
13-30621237-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
13-30621782-G-A | not specified | Uncertain significance (May 02, 2024) | ||
13-30621849-G-A | not specified | Uncertain significance (Oct 12, 2024) | ||
13-30630845-C-G | not specified | Uncertain significance (Dec 16, 2023) | ||
13-30630863-T-G | not specified | Uncertain significance (Nov 21, 2022) | ||
13-30630867-T-A | not specified | Uncertain significance (Apr 13, 2022) | ||
13-30630870-C-A | not specified | Uncertain significance (Dec 07, 2021) | ||
13-30630880-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
13-30630894-A-C | not specified | Likely benign (Feb 22, 2023) | ||
13-30630989-A-G | not specified | Uncertain significance (Oct 11, 2024) | ||
13-30630997-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
13-30631009-A-C | not specified | Likely benign (Aug 04, 2024) | ||
13-30631019-A-G | not specified | Uncertain significance (Oct 01, 2024) | ||
13-30631031-A-G | not specified | Uncertain significance (Aug 29, 2024) | ||
13-30631034-G-A | not specified | Uncertain significance (Nov 07, 2022) | ||
13-30631039-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
13-30631112-T-C | not specified | Uncertain significance (Dec 10, 2024) | ||
13-30631117-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
13-30631199-G-A | not specified | Uncertain significance (Nov 09, 2022) | ||
13-30631201-C-A | not specified | Likely benign (Apr 13, 2023) | ||
13-30631267-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
13-30631307-C-T | not specified | Uncertain significance (May 04, 2023) | ||
13-30631349-C-T | not specified | Likely benign (Mar 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USPL1 | protein_coding | protein_coding | ENST00000255304 | 8 | 41857 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0218 | 0.978 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.427 | 528 | 556 | 0.949 | 0.0000269 | 7142 |
Missense in Polyphen | 115 | 139.76 | 0.82284 | 1985 | ||
Synonymous | 0.0532 | 209 | 210 | 0.995 | 0.0000108 | 2121 |
Loss of Function | 4.24 | 11 | 39.9 | 0.276 | 0.00000191 | 570 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000211 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000141 | 0.000139 |
European (Non-Finnish) | 0.000170 | 0.000167 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000229 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: SUMO-specific isopeptidase involved in protein desumoylation. Specifically binds SUMO proteins with a higher affinity for SUMO2 and SUMO3 which it cleaves more efficiently. Also able to process full-length SUMO proteins to their mature forms (PubMed:22878415). Plays a key role in RNA polymerase-II- mediated snRNA transcription in the Cajal bodies (PubMed:24413172). Is a component of complexes that can bind to U snRNA genes (PubMed:24413172). {ECO:0000269|PubMed:22878415, ECO:0000269|PubMed:24413172}.;
Recessive Scores
- pRec
- 0.0852
Intolerance Scores
- loftool
- 0.724
- rvis_EVS
- 0.45
- rvis_percentile_EVS
- 78.05
Haploinsufficiency Scores
- pHI
- 0.109
- hipred
- N
- hipred_score
- 0.233
- ghis
- 0.498
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Uspl1
- Phenotype
Zebrafish Information Network
- Gene name
- uspl1
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- curved dorsal
Gene ontology
- Biological process
- cell population proliferation;snRNA transcription;protein desumoylation;Cajal body organization
- Cellular component
- extracellular space;Cajal body
- Molecular function
- protein binding;SUMO binding;ubiquitin binding;SUMO-specific isopeptidase activity